Callaway James Eric 4
4 · Xenetic Biosciences, Inc. · Filed Oct 13, 2017
Insider Transaction Report
Form 4
Callaway James Eric
Director
Transactions
- Award
Stock Option
2017-10-11+6,250→ 12,500 totalExercise: $2.95From: 2018-04-11Exp: 2027-10-11→ Common Stock (6,250 underlying) - Award
Stock Option
2017-10-11+6,250→ 18,750 totalExercise: $2.95From: 2018-07-11Exp: 2027-10-11→ Common Stock (6,250 underlying) - Award
Stock Option
2017-10-11+6,250→ 25,000 totalExercise: $2.95From: 2018-10-11Exp: 2027-10-11→ Common Stock (6,250 underlying) - Award
Stock Option
2017-10-11+6,250→ 6,250 totalExercise: $2.95From: 2018-01-11Exp: 2027-10-11→ Common Stock (6,250 underlying)
Footnotes (1)
- [F1]On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date.